Nakamoto Inc (NAKA) Stock Research

Over a week ago

Crypto Currents: ICE, OKX form U.S. crypto joint venture

+34

Jun 26, 9:40 AM

Crypto Currents: Coinbase launches Coinbase for Agents service

+33

Jun 12, 9:38 AM

Crypto Currents: Nakamoto sells 600 BTC to regain Nasdaq compliance

+11

Jun 11, 12:08 PM

Nakamoto regains Nasdaq compliance

NAKA

Jun 11, 8:14 AM

Nakamoto board authorizes $25M share repurchase program

NAKA

Jun 11, 8:14 AM

Nakamoto annnounces capital structure, treasury management initiatives

NAKA

Jun 11, 8:13 AM

Nakamoto appoints Tyler Evans to board of directors

NAKA

May 22, 8:04 AM

Kindly MD Inc trading halted, news pending

NAKA

May 21, 7:50 PM

Crypto Currents: Tether buys out SoftBank's Twenty One Capital stake

May 20, 11:03 AM

Nakamoto announces 1-for-40 reverse stock split

NAKA

May 20, 9:07 AM

Nakamoto reports Q1 EPS (38c) vs (17c) last year

NAKA

May 13, 5:01 PM

UTXO Management announces UTXO Preferred Income Strategies

NAKA

Apr 27, 9:07 AM

Nakamoto announces details of actively managed Bitcoin derivatives program

NAKA

Apr 24, 8:32 AM

Nakamoto management to meet virtually with B. Riley

NAKA

Apr 14, 10:12 AM

Crypto Currents: Potential buyers reportedly looking at Gemini assets

+38

Apr 10, 11:37 AM

Nakamoto files $6.99B mixed securities shelf

NAKA

Apr 9, 5:29 PM

Nakamoto files to sell 352.54M shares of common stock for holders

NAKA

Apr 9, 5:28 PM

Nakamoto initiated with bullish view at TD Cowen

NAKA

Apr 9, 4:15 PM

Nakamoto price target lowered by 75c at Maxim, here's why

NAKA

Apr 6, 8:57 AM

Nakamoto reports Q4 EPS 7c vs (17c) last year

NAKA

Mar 30, 5:51 PM

Kindly MD Inc options imply 0.9% move in share price post-earnings

NAKA

Mar 30, 2:34 PM

Crypto Currents: Strategy pauses buying as Bitmine adds billions in ether

+20

Mar 30, 11:45 AM

Kindly MD Inc options imply 1.2% move in share price post-earnings

NAKA

Mar 23, 1:19 PM

Kindly MD Inc options imply 1.3% move in share price post-earnings

NAKA

Mar 19, 3:04 PM

Direct-to-Consumer (DTC) Telehealth Model: Kindly Md bypasses traditional healthcare intermediaries, offering a seamless online experience from consultation to prescription delivery, enhancing convenience and accessibility for patients.

Specialized Niche Focus: By concentrating on specific, often sensitive, medical conditions like ED and andrology, NAKA builds expertise and trust within these markets, allowing for highly targeted marketing and efficient service delivery.

Subscription-Based Revenue Model: The company leverages a recurring subscription model for its services and products, ensuring predictable revenue streams and fostering long-term customer relationships through continuous engagement.

Regulatory Compliance Risks: Failure to adhere to evolving healthcare laws and regulations, including FDA, HIPAA, and state medical board requirements, could result in fines, loss of licenses, or operational shutdowns.

Market Competition Risks: Intense competition from established healthcare providers, telehealth platforms, and pharmaceutical companies could limit market share, pressure pricing, and reduce profitability.

Product Efficacy and Safety Risks: The potential for products or services to be deemed ineffective, unsafe, or to have unforeseen adverse effects could lead to product recalls, lawsuits, and severe reputational damage.